FRX:TSX, Fennec Pharmaceuticals Inc.

FRX stock overview

Fennec Pharmaceuticals Inc. (FRX:TSX) closed at $13.29 on November 5, 2026, unchanged on the day. The stock trades 24.7% below its 52-week high of $17.64 and 75.1% above its 52-week low of $7.59. Over the past year, it gained 21.7%. Fennec Pharmaceuticals Inc. is part of the Life Sciences sector (Biotechnology).

Key figures

Price
$13.29
Day change
0.00%
Volume
1
Average volume
480
Market cap
466M+
52-week range
$7.59 – $17.64
50-day average
$15.34
200-day average
$12.87

Price action over the past year

In 252 trading sessions since November 6, 2025, FRX closed higher on 74 days (29%). Its best day was May 14, 2026 (+36.31%) and its worst was March 24, 2026 (-18.62%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 13 times.

Recent signals

FRX news

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.

Similar stocks

Find more stocks like FRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.